We've detected that Javascript is not enabled. It is required for an optimal survey taking experience.
Please check your browser's settings and make sure Javascript is turned on. Learn how to enable Javascript.

Skip survey header

9937 HTC Readiness – A Global Perspective Podcast 1

DEMOGRAPHICS

2. If Other, please specify: *This question is required.

3. If Other, please specify: *This question is required.

3. What is your role in the care of individuals with hemophilia? Select all that apply *This question is required.

Physician involved in direct patient care (management and monitoring of bleeding risk)
Investigator in clinical trials of patients with hemophilia
Perform assays/assessments in a specialized coagulation laboratory
Physical, occupational, and/or mental health therapy
Basic research related to hemophilia, but not related to patient care
Patient education
Other - specify Please enter an 'other' value for this selection.

6. Please rate your KNOWLEDGE of the considerations for hemophilia treatment centers in anticipation of the availability of gene therapy for patients with hemophilia:
*This question is required.

Space Cell	0 Not relevant	1 Low	2	3	4	5 High
BEFORE this educational activity:	BEFORE this educational activity:: 0 Not relevant	BEFORE this educational activity:: 1 Low	BEFORE this educational activity:: 2	BEFORE this educational activity:: 3	BEFORE this educational activity:: 4	BEFORE this educational activity:: 5 High
AFTER this educational activity:	AFTER this educational activity:: 0 Not relevant	AFTER this educational activity:: 1 Low	AFTER this educational activity:: 2	AFTER this educational activity:: 3	AFTER this educational activity:: 4	AFTER this educational activity:: 5 High

7. Please rate your ABILITY to provide education to patients and peers about the pre- and post-infusion requirements for dosing and managing patients who undergo gene therapy. *This question is required.

Space Cell	0 Not relevant	1 Low	2	3	4	5 High
BEFORE this educational activity:	BEFORE this educational activity:: 0 Not relevant	BEFORE this educational activity:: 1 Low	BEFORE this educational activity:: 2	BEFORE this educational activity:: 3	BEFORE this educational activity:: 4	BEFORE this educational activity:: 5 High
AFTER this educational activity:	AFTER this educational activity:: 0 Not relevant	AFTER this educational activity:: 1 Low	AFTER this educational activity:: 2	AFTER this educational activity:: 3	AFTER this educational activity:: 4	AFTER this educational activity:: 5 High

PRACTICAL APPLICATION

9. *If yes or possibly considering changes, please check off what you intend to do differently or incorporate into your clinical practice as a result of this educational activity.

Discuss considerations for HTC gene therapy readiness with peers and colleagues
Stay up-to-date with new developments related to the administration and management of gene therapy
Anticipate the follow-up needs and monitoring for patients who undergo hemophilia gene therapy
Develop educational resources addressing HTC readiness for members of the hemophilia care team
Other - specify Please enter an 'other' value for this selection.

9. If you answered no, why not:

9. Please provide a specific way in which this activity will impact your patient care. *This question is required.

SATISFACTION

10. Was the format of this educational activity appropriate for the content presented? *This question is required.

11. Did this educational activity meet your learning needs?

12. What educational topics would you like to see addressed in future activities? *This question is required.

13. Was this activity scientifically sound and free of commercial bias or influence? *This question is required.

14. If “No” please explain:

14. FOR EUROPEAN UNION AND UNITED KINGDOM LEARNERS ONLY:
The France Foundation would like to send you educational opportunities relevant to your practice, emailed to the address you provided. May we have your consent?